Alpine Global Management’s Starling Oncology Institute, Inc. Common Stock STLN Stock Holding History

Alpine Global Management’s Portfolio STLN Stock Details STLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-46,326	Closed	-$76K	–	398
2022 Q4	$76K	Buy	+46,326	New	+$130K	0.03%	366
2022 Q2	–	Sell	-40,951	Closed	-$292	–	636
2022 Q1	$292	Sell	40,951 -344,037	-89%	-$2.32M	0.07%	186
2021 Q4	$3.75M	Buy	+384,988	New	+$3.42M	0.55%	34
2020 Q4	–	Sell	-64,081	Closed	-$664K	–	298
2020 Q3	$664K	Buy	+64,081	New	+$666K	0.14%	98

Other funds holding STLN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Alpine Global Management's STLN Position: Q1 2023 in Review

Alpine Global Management sold out of Starling Oncology Institute, Inc. Common Stock (STLN) in Q1 2023, closing a stake of 46,326 shares — an estimated $76K sold.

Alpine Global Management first reported a position in STLN in Q3 2020 and held it in 4 quarters. The position peaked at $3.75M in Q4 2021. 39 funds tracked by Wall St. Rank hold STLN as of Q1 2023.

Alpine Global Management reported no remaining Starling Oncology Institute, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Alpine Global Management sold 46,326 Starling Oncology Institute, Inc. Common Stock shares in Q1 2023, an estimated $76K.
Alpine Global Management first reported a position in Starling Oncology Institute, Inc. Common Stock in Q3 2020 and held it in 4 quarters.
Alpine Global Management's Starling Oncology Institute, Inc. Common Stock position peaked at $3.75M in Q4 2021.
39 funds tracked by Wall St. Rank held Starling Oncology Institute, Inc. Common Stock as of Q1 2023.

Based on Alpine Global Management's 13F filing for Q1 2023, filed 15 May 2023.